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ABSTRACT 
To evaluate the impact of maternal HIV-infection on routine childhood immunization 
coverage, comparison was made on the immunization status of children born to HIV-infected 
and HIV-uninfected women in rural KwaZulu Natal. The study population was all children 
enrolled in the routine demographic surveillance system as at 31
st
 December 2005 (n=18,171) 
in Africa Centre Demographic Surveillance Area.  Sampling of subjects was done based on 
the dates of birth that were between the period 1
st
 Jan 2004 and 31
st
 December 2005 
(n=2,020). This was further divided based on maternal HIV status namely; 236 HIV (+), 777 
HIV (-) and 1,007 HIV (unknown).  The main outcome measure was the percent of complete 
routine childhood immunizations recommended by the WHO as assessed from the Road-to-
Health cards or maternal recall during household interviews. For all vaccines, children born to 
HIV-infected mothers had lower immunization coverage than children born to HIV-negative 
mothers (78.21% vs. 86.52%). The children of mothers who were HIV-infected were 31-55% 
(P-value <0.020) less likely to be immunized compared to children of mothers who were HIV-
uninfected.  
We conclude that maternal HIV-infection is associated with childhood under immunisation. 
VCT health workers should encourage HIV-infected mothers to complete childhood 
immunization. Improving access to immunization services could benefit vulnerable 
populations such as children born to HIV-infected mothers.  
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DEFINITION OF TERMS 
APGAR score- a simple and repeatable method to quickly and summarily assess the health of 
newborn children immediately after childbirth. It is determined by evaluating the newborn 
baby on five simple criteria on a scale from zero to two and summing up the five values thus 
obtained.
1
 
Resident members – Are members of the households within the Africa Centre DSA who have 
been residing within those households for a period exceeding four months. 
49
 
Primary road - a road that forms the major routes between the major urban centres.
48
 In the 
South African context, it is known by as N-series. 
Mobile clinic points– Designated points throughout the district (e.g. primary schools, shopping 
centers, churches etc) that are visited twice monthly by a mobile clinic. The services offered 
during this visits are; family planning services, child immunization, antenatal care and 
treatment of chronic illnesses. 
48
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ACRONYMS AND ABBREVIATIONS 
BCG Bacillus Calmette Guerin 
OPV Oral Polio Vaccine 
DTP Diphtheria Tetanus Pertusis 
DSA Demographic Surveillance Area 
ACDIS Africa Centre Demographic Information System 
DHS Demographic Health Survey 
GIS Geographic Information System 
EPI Expanded Programme on Immunization 
WHO World Health Organization 
UNICEF United Nations International Children’s Emergency Fund 
CHF Child Health Form 
ARV Anti-retroviral  
VCT Voluntary Counseling and Testing 
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
In this chapter, background information including the importance and general coverage of 
vaccination is reviewed. The problem statement and justification for the study is explained. 
The published literature on the possible determinants of vaccination coverage is reviewed and 
the chapter ends by describing the aims and objectives of the study. 
 
1.1 Background information 
The Expanded Programme on Immunization was started in 1974 by WHO/UNICEF for less 
developed countries. It was called “expanded” for two reasons. First, polio and measles 
vaccines were added
 
to BCG and DTP vaccines. Second, the proportion of children
 
in 
developing countries who were immunized was substantially increased.
2
 Immunization has led 
to spectacular reductions in mortality in both developed and developing countries.
3
 Vaccines, 
which protect against disease by inducing immunity around the world, are widely and 
routinely administered based on the common-sense principle that it is better to prevent people 
from falling ill than to treat them once they do. Suffering, disability and preventable death are 
avoided.  
It is estimated that immunization averted about two million deaths of infants in 2003 as well as 
an additional 600,000 hepatitis-B related deaths that would have occurred in adulthood (from 
cirrhosis and cancer).
4
 Routine immunization is now provided in developing countries and 
many parts of sub-Saharan Africa against Measles, Polio, Diphtheria, Tetanus, Pertussis, 
Hepatitis-B and Tuberculosis. The global coverage of infants in 2004 with 3 doses of DTP 
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vaccine was 78%, 3 doses of polio vaccine 80% and one dose of measles 76%. Further, by 
2004, a total of 153 countries had integrated Hepatitis-B vaccination.
5
 
The use of conjugate vaccines for the prevention of Haemophilus influenza type b (Hib) 
disease in children has substantially decreased the burden of disease in developing 
countries.
6,7,8 
However, they are not used in some developing countries due to their high cost 
and because Hib remains under-recognized as a cause of severe disease and death.
9
 South 
Africa was the first country in Africa to self-finance and incorporate the Hib vaccine into its 
routine child immunization schedule from July 1999.
10
 Since its incorporation, the number of 
Hib cases, among children below one year of age decreased by 65%, from 55 cases in 1999-
2000 to 19 cases in 2003-04. This is based on the number of cases reported to the national 
surveillance system 
11
 
The national vaccination status schedule in South Africa includes BCG, OPV, DTP, Hib, 
Hepatitis B and Measles vaccine. These vaccines are provided free of charge at local clinics 
and community health centers in South Africa. All children have a right to basic health care, of 
which immunization is one of the components. The Expanded Programme on Immunization in 
South Africa aims for 90% full immunization coverage amongst children at 1 year of age. 
According to the 2003 statistics, the routine immunization coverage was 82%, which was 
above the WHO recommendation for routine immunization coverage of 80%.
12 
The routine 
vaccination schedule in South Africa for children’s first year of life is shown in the table 
below: 
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Table 1: National vaccination schedule for children under 1 year of age in South Africa 
Age Vaccine 
Birth BCG, Polio0 
6 weeks Polio1, DTP1, HepB1, Hib1 
10 weeks Polio2, DTP2, HepB2, Hib2 
14 weeks Polio3, DTP3, HepB3, Hib3 
9 months Measles 
Immunization is a proven tool for controlling and even eradicating disease. However, the 
determinants of vaccination coverage are thought to vary with different settings, for instance, 
across social groups, distance traveled to health care facilities, distance traveled to transport 
infrastructure, maternal HIV status or with varying maternal education level. Thus, it is 
imperative to examine these factors that determine vaccination coverage so as to advocate for 
interventions that will increase childhood vaccination coverage. 
This study assessed the vaccination coverage and the determinants of this coverage in rural 
KwaZulu-Natal (Hlabisa district). However, for data reasons, we could not include vaccination 
against Haemophilus influenza type b (Hib), which may also prevent a relatively large number 
of childhood deaths. 
13
 
 
1.2 Problem statement 
Routine child vaccination has been known to reduce infant mortality by preventing diseases. 
However, a previous study conducted in Hlabisa health district indicated that 76% of children 
had received all the vaccines due to a 12-month-old child, and 78% of these had received all 
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doses by 12 months of age.
14
 The study aims at investigating why some children were 
vaccinated while others were not in an area served by Africa Centre.  
 
1.3 Justification 
Vaccination coverage rates are accepted as an indicator of the performance and adequacy of 
primary paediatric health care services
15
 and are also a useful tool in program management 
and decision making.
16
 Vaccination coverage has been shown to be primarily hampered by 
difficulty in assessing primary care, complex transport requirements and by user 
characteristics, such as parental education, late birth order, household structure and socio-
economic status in other rural areas.
17,18,19
  A clear understanding of these factors will assist in 
strengthening the primary paediatric health care services in the Africa Centre Demographic 
Surveillance Area (DSA) which also has a high HIV prevalence (40%) among mothers 
attending prenatal clinics.
20
 
 
1.4 Hypothesis 
• There is no difference in vaccination coverage by maternal HIV status. 
• There is no difference in vaccination coverage by distance from the household to the 
nearest fixed clinic, mobile clinic point and primary road. 
 
1.5 Literature review 
Infant mortality has traditionally been viewed as an indicator of the social and economic well-
being of a society. It reflects not only the magnitude of those health problems which are 
directly responsible for the death of infants but the effect of a multitude of other factors, 
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including prenatal and post-natal care of mother and infant, and the environmental conditions 
to which the infant is exposed.
21
 Due to the association between child immunization and child 
survival
4
, a large component of the factors affecting child survival also affect child 
immunisation for instance maternal HIV status, maternal education level, access to health care 
facility, socio-economic status of the household where the child is brought up among others.  
 
Maternal HIV Status 
A previous study conducted in Rakai District, Uganda showed that the percent coverage for all 
childhood vaccines was lower among children born to HIV-infected mothers than children 
born to HIV-uninfected mothers. The difference was greatest for measles and DTP3, with 
coverage being 7% lower for children of HIV-infected mothers.
22
 Coverage was also affected 
by whether a mother had knowledge of her HIV status. The odds of being under immunized, 
for children of both HIV-infected and HIV-uninfected mothers who did not know their status, 
increased to 1.56 (95% CI 0.86-2.83) & 1.68 (95% CI 1.07- 2.63) respectively, while the odds 
of children born to HIV-infected women who knew their status was doubled to 2.21 (95% CI 
1.14-4.29). This implies that the risk of under immunization increases not only with HIV-
infection but also with the knowledge of maternal HIV status. This could be due to the fact 
that women who are HIV-infected tend to change their health seeking behaviour when they 
know their HIV-status and this may negatively affect their child’s heath. The impact of 
learning about their HIV-infection may cause psychological effects like depression which 
have a direct effect on their child-care. 
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Maternal Education  
Widespread awareness of the importance of mother’s education on their children’s health is 
commonplace in research. For instance, Caldwell argued that maternal education is the single 
most significant determinant of child health and child mortality and no other factor has such 
impact. Maternal education cannot thus be employed as a proxy for general social and 
economic change but must be examined as an important factor in its own right.
23  
Some possible links and pathways that result in greater utilization of modern health services 
are; education is associated with greater knowledge of the protective functions of child 
immunization and greater awareness of proper immunization schedules.
24
 Schooling equips 
women with special skills and dispositions that significantly predict the use of medical 
services and changes in household health behaviour.
25
 Potential health benefits from delayed 
and lower fertility among an educated woman enable greater investments in the child.
26
 
Finally, education endows a woman with the ability to access relevant health services, interact 
effectively and assimilate information relating to family planning, prenatal care, childhood 
immunizations and nutritional needs.
27
  
   
Distance to health care facility 
Geographic accessibility can be measured by the following factors: the physical separation 
that limits contact, represented as Euclidean distance; distance along a road network; travel 
time or travel costs.
28
 Stronger associations have been found with road distance and estimated 
travel time than with Euclidean distance.
29
 Further, there is a cogent argument that Euclidean 
distance is a sub-optimal measure of isolation since it ignores physical barriers such as rivers, 
swamps, hills, road and traffic system and socio-cultural factors. These can greatly influence 
the actual distance traveled.
30 
 
 18 
Travel time models have some limitations when compared to actual distances travelled. Travel 
time assumes ubiquitous coverage of public transport which is unlikely in a rural setting. It is 
usual to wait hours for another bus or taxi. Similarly, it assumes public transport is used on 
average behaviour while this differs from area to area. Further, travel time differs with age and 
sex. These individual factors are not accounted for in travel time.
28
 
Distance to the clinic, a proxy measure of accessibility, has been found to affect immunization 
coverage in 2006 in Kenya
31
. Close proximity to the clinic was also associated with an 
increased likelihood of vaccination, with immunization coverage declining with increasing 
distance from vaccination clinics in Egypt
32
 and in Pakistan.
33
 A possible explanation of this 
could be that visibility of a clinic may attract a parent’s attention and/or act as a reminder to 
the parent of the immunization status of the child.  
A study that investigated the accessibility and utilization of clinics in Hlabisa district, rural 
South Africa showed that the mean travel time to the nearest clinic is 77 min (median 81 min) 
and that 64.8% of the homestead travel at least one hour to attend a clinic. Compared with 
other districts in South Africa and Africa, this suggests that patients in the district travel 80% 
longer than the reported provincial coverage and that the proportion of the population who live 
in the vicinity of more than one hour travel time to health care facility is double the national 
rural average.
28
  
Travel time to clinic is only a proportion of the total time expenditure in getting health care. 
Studies in South Africa measure the time taken to receive a treatment as 42 minutes
34
 and 
estimate that 35% of patients wait for an hour or more to receive primary health care.
35
 Other 
studies in Africa show that people spend more time waiting to receive treatment than 
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travelling to clinic with an average waiting time of 150-160 minutes.
36
 Travel time becomes 
an indicator of vaccination coverage because where the majority of mothers/caregivers have to 
make a journey to a health facility, they may prefer more accessible alternate sources of child 
care. 
 
Urban-rural differentials  
Urban-rural differences in vaccination coverage have been previously observed in Niger and 
Nigeria. In Niger, only 1 in 10 rural children have received all the eight immunizations 
compared to half of urban children while the overall vaccination coverage levels in rural areas 
are less than half of those for urban children for BCG and measles. Further, due to higher drop 
out rates from the health system in rural areas in Niger, coverage levels for the third dose of 
DPT and polio are less than one-quarter of the rates seen in urban areas.
37
 In Nigeria, rural-
urban differences in vaccination coverage, though marked, are not as large as those seen in 
Niger. In the case of BCG and measles vaccines, rural coverage levels are about two-thirds of 
the levels in urban areas.
33 
In Eastern Turkey, measles vaccination was found to be higher in 
urban regions than suburban and rural regions.
38
  
 
Socio-economic status  
Previous studies have shown that socio-economic status of the family play an important role in 
determining vaccination compliance with higher socio-economic status being associated with 
higher rate of vaccination.
39,40
 In Bangladesh, children of relatively better-off households 
(owning 4-6 household articles) had an 80% higher chance of being fully immunized 
compared to the economically disadvantaged group (owning at most one household article).
41
  
This may be due to the fact that children who are poor are hardest to reach by the health 
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services and parents may encounter more barriers to reach them compared to those of better 
socio-economic status. However, other studies have found no difference in vaccination rates 
with respect to socio-economic status.
18, 34
   
 
Other factors 
Sex discrimination in child immunization has been found to exist in rural Bangladesh with 
female children being 30% less likely to be fully vaccinated compared to male children.
41
 
Similar findings have been reported in other studies. 
42,43
 
Marital status of the mother has been found to play an important role in predicting child health 
in developing countries. 
44,45
 In Central Asia, the risk of under vaccination for children of 
unmarried mothers was 70% higher than for married mothers.
40
 This may be due to the fact 
that in many societies, marriage provides a better social life which may be associated with 
better child health.  
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CHAPTER 2: METHODOLOGY 
2.1 Study aims and objectives 
Primary objective 
The main aim of this study was to investigate why some children are vaccinated while others 
are not. 
 
Secondary objective 
1. To determine the vaccination coverage among children aged 12-23 months in the Africa 
Centre Demographic Surveillance Area (DSA). 
2. To investigate whether maternal HIV status influences vaccination coverage in children 
aged 12-23 months when controlling for maternal age, maternal education, household wealth, 
the child’s sex, birth order, and the distance from the household to the nearest fixed clinic, 
mobile clinic point and primary road. 
 
2.2 Research design  
This was an analytical cross-sectional study of children recruited and followed up from 1
st
 
January 2000 to 31
st
 December 2005. The study utilized primary data collected twice per year 
at Africa Centre DSA.  
 
2.3 Study area and study population  
Hlabisa health sub-district is located within the rural district of Umkhanyakude in northern 
KwaZulu Natal (Appendix 1), covering an area of 1,430 km
2
. The sub-district is about 250 km 
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north of the city of Durban (the third largest city in South Africa).
 
Since 1998, the Africa 
Centre for Health and Population studies has maintained a Demographic Information System  
(ACDIS) in KwaZulu-Natal, the largest province South Africa, stretching from the southern 
borders of Swaziland and Mozambique to the Eastern Cape border in the south. Its 
headquarters are located near Mtubatuba in Hlabisa sub-district. Births, deaths, migrations, 
marriages, and socioeconomic status are recorded on some 11,000 households in a 438 square 
kilometer area of the Hlabisa sub-district. The total population surveyed was approximately 
90,000 Zulu speaking people, of whom 3.3% were located in a formal urban township 
(KwaMsane), 19.9% in peri-urban areas (informal settlements with a population density of 
more than 400 people per km
2
), and the remaining 76.8% were classified as living in a rural 
area.
46
 The rural population lives in scattered homesteads that are not concentrated in villages 
or households, as is the case in many parts of Africa. 
The community, like many others in the province of KwaZulu Natal is in the throes of an 
unprecedented health crisis, with HIV prevalence close to 40 percent in women attending 
prenatal clinics.
20
 In the sub-district, there is a central community hospital and 13 fixed clinics 
which provide the bulk of the primary health care in Hlabisa. In addition, 30 mobile clinic 
points are visited twice monthly, and 130 community health workers are each expected to visit 
regularly a group of assigned homesteads.
47
 To access primary health care, two-thirds of the 
population walks to clinics, while the remaining one-third uses public transport. A negligible 
number (0.4 %) use their own transport to access care.
48
  
The whole population of children, born between 1
st
 Jan 2000 and 31
st
 Dec 2005, in the 11,000 
households in the Demographic Surveillance System, was included. The age group was chosen 
because the WHO recommends that if vaccination coverage is to be investigated, the children 
 23 
should be older than 11 months of age. This is because by this age, they have received all the 
vaccines that are due to them in their first year of life.  
Secondly, this was consistent with other surveys on vaccination and more so with the DHS. 
Thus comparisons between the Demographic Surveillance Area with provincial results and 
also other studies done in different countries could be done.  
 
2.4 Sample size  
The sample included all children born between 1
st
 Jan 2004 and 31
st
 Dec 2005, in Africa 
Centre which totalled to 3,058 children. This was from a total of 18,171 children born between 
1
st
 Jan 2000 and 31
st
 Dec 2005, whose vaccination information was available in the ACDIS. 
We could not include all the 18,171 children because data on socio-economic status and 
maternal HIV status information were available from the year 2004 and these were important 
independent variables that were explored in this study. 
Out of the 3,058, 2,020 (66%) were included in the logistic regression analysis because they 
had complete information on the independent variables. The rest (n=1,038) were dropped 
because they had missing information on independent variables. For the purposes of this 
analysis, we categorized maternal HIV status as; HIV Positive 236 (12%), HIV Negative 777 
(38%) and HIV unknown 1,007 (50%).  
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Figure 1 Summary of sampling and sample size selection 
 
2.5 Data sources  
2.5.1 Data  
Data were obtained from the Africa Centre Demographic Information System (ACDIS) in 
South Africa. ACDIS has two separate cycles of data collection – household and individual. 
During the household data collection cycle, a set of questionnaires are routinely administered 
every six months (Table 2) to a key informant in each household.
49
 Information recorded are 
Unknown HIV 
status 1,007 
Socio-economic 
status and maternal 
HIV collected from 
year 2004 
HIV Positive 
236 
HIV Negative 
777 
Sample 
Date of Birth: 
1st Jan 2004 to 31st Dec 
2005 (3,058) 
Study Population 
Date of Birth: 
1st Jan 2000 to 31st Dec 
2005 (18,171) 
1,038 children dropped because 
had missing information on 
independent variables in 
regression analysis 
Sample in logistic 
regression analysis 
2,020 
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key attributes and events regarding physical structures, household and individuals and their 
relationship to each other. Additional modules administered include; household socio-
economic data, individual socio-economic data and child grants. The HIV surveillance 
comprises part of the individual data collection cycle, undertaken annually, and requires an 
interview with the eligible persons due to the sensitivity of the questions.  
 
Table 2: Data collected at each routine household visit, 2000 and ongoing  
Subject    Types of information 
Homestead    Latitude, longitude 
Owner 
Number of households 
Household    Formation and dissolution 
Household head 
Individual    Individual details: inc. date of birth, sex, parents 
Household membership(s) 
Household members  Update household list: members who join, leave or die 
Residency status, marital and partnership status. Relationship to 
household head 
Births  Pregnancy outcomes: abortions, still and live births. Delivery 
environment: inc. assistance, place birth weight, APGAR 
Deaths  Location and care provision at time of death. Open description 
of circumstances 
Migrations    Details of place of origin or destination 
Type of migration, e.g. household or individual migration 
Child health    On first birthday: vaccination history 
 
2.5.2 Immunization data 
A Child Health Form (CHF) is used to collect immunization data at Africa Centre (Appendix 
4). This form is only filled in for children who are between 1 year and 4 years of age and are 
resident in the households within the DSA. 
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Data on immunization has been collected annually since 2000, and once retrospectively for all 
children ever born between 1995 and 2000 to mothers who were residents in the ACDIS DSA 
in 2000. Immunization data, including the dates of immunization, are available for the 
following vaccines: BCG, Diphtheria-Tetanus-Pertussis (DTP), Oral Polio Vaccine (OPV), 
Hepatitis B (HepB) and measles vaccinations. These vaccines are the complete set of vaccines 
included in the South African National Childhood Immunization Schedule (Table 1), with the 
exception of the Haemophilus influenzae type B (Hib) vaccine, which has recently been added 
to the ACDIS data collection schedule as from January 2008. 
 
2.5.3 HIV surveillance data  
Data were used from the first round (January to December 2004) and the second round 
(January to December 2005) of a prospective population-based HIV survey. During data 
collection process (Appendix 5), teams of two trained fieldworkers visited each eligible 
individual in his or her household. Fieldworkers revisited households up to four times to 
contact absentees. If a subject no longer lived at the household, the field worker handed the 
case to a specially trained tracking team that made up to 10 attempts to find the individual in 
his or her new residence. After written informed consent, the field workers collected blood by 
finger stick and prepared dried blood spots for HIV testing according to the Joint United 
Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO) 
Guidelines for Using HIV Testing Technologies in Surveillance.
50
 HIV status was determined 
by antibody testing with a broad-based HIV-1/HIV-2 enzyme-linked immunosorbent assay 
(ELISA; Vironostika, Organon Teknika, Boxtel, the Netherlands) followed by a confirmatory 
ELISA (GAC-ELISA; Abbott, Abbott Park, Illinois, USA). 
 27 
 
2.5.4 Household asset data 
A household assets index is used as a measure of wealth. Household assets indices are valid 
proxies of wealth in rural Africa as shown by Morris and colleagues.
51
 The household assets 
included in this analysis are: Household furnishings (Bed, sofa, table/chair), bicycle, block-
maker, car, electric stove with oven, electric hot plate, electric kettle, fridge/freezer, gas 
cooker, lorry/tractor, motorcycle/scooter, radio, sewing machine, telephone, cellphone, 
television set, video cassette recorder and wheelbarrow. Wealth index was calculated from 
these assets using the principal component analysis method.
52
 Households are categorised 
households as either belonging to the poorest 40%, the middle 40% or the wealthiest 20% on 
the assets index scale.  
 
2.6 Measurements  
Vaccination coverage 
The main outcome measure was complete vaccination for children who are aged 12-23 
months. The vaccinations given by the first year of life are; measles vaccine, Diptheria-
Tetanus-Pertusis (DTP3), Haemophilus influenzae type B (Hib), Poliomyelitis (Polio 3), 
Hepatitis B (HepB3) and BCG vaccine. Each of these was treated as separate dependent 
variables. BCG in South Africa is given at birth and if not it is given at any other time the 
child is presented to the clinic. Though Polio is given at the same time with DTP, Hib & HepB 
(6, 10 & 14 weeks), unlike the latter, it can be administered though routine immunization or 
through immunization campaigns. Measles is administered much later on, at 9 months of age 
and it can be administered through routine immunizations or through immunization 
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campaigns. The age cut-off corresponding to the first birthday was chosen because WHO 
recommends that vaccination should be assessed for children after this age.
4
 This allows a 
three months period for children to receive measles immunization.  
 
To allow an appraisal of the trends in timeliness of vaccines given as children get older, four 
categories were used. For each vaccine, the proportion of children receiving their vaccines 
on/before their due dates, within 28 days after their due date, within 42 days of the due date 
and after 42 days of the due date were calculated. This method has been used in other rural 
areas of South Africa.
53
  
 
 
Determinants of vaccination coverage 
The determinants of vaccination included as independent variable were; maternal education, 
maternal HIV status, maternal age, shortest distance from the household to the health care 
facility (mobile/fixed), shortest distance from the household to the nearest primary road, 
economic status of the household (wealth index) and sex of child.  
Maternal education was included because the association between a mother’s education and 
the likelihood of her child being vaccinated is well documented.
30,33,54,55
 We also included 
distance to health care facility because various studies have found an association between 
distance to health facility and vaccination coverage.
16,26,32,56
 Socio economic status, measured 
in terms of household wealth, was included as an independent variable because children from 
the poorest  households, who also live furthest from the health facilities, incur indirect costs 
(in terms of travel time to health facilities) making it difficult to avail themselves for services 
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that exist in the community.
16,40 
Maternal HIV status was included as an independent variable 
because given the high HIV prevalence of women visiting prenatal clinics
43
 in the study area, 
it was important to investigate the effect of maternal HIV status on vaccination coverage. 
Further, maternal HIV status has been documented to be associated with vaccination 
coverage.
20
  
The difference between our study and the Rakai study in Uganda that investigated maternal 
HIV status and vaccination coverage
22
 was that; the Rakai study was based on participants 
who visited a Voluntary Counseling and Testing (VCT) centre while our study was 
population-based and participants were visited in their homes by community interviewers and 
tested for HIV after consenting. Further, the Rakai sample included children aged 6 to 35 
months of age while our sample was children aged 12-23 months of age. The Rakai study 
adjusted the interaction between HIV-infection and maternal knowledge of HIV status, for 
number of antenatal visits, knowledge that a child should complete immunization by nine 
months of age, belief that it is permissible to immunize a symptomatic child born to an HIV 
infected mother and usual immunization venue (government or other). Our study adjusted for 
distance to health care facility among other factors because of the general weakness associated 
with the HIV-related disease which makes it more difficult for the HIV-positive mother to 
bridge the distance to the health facility.    
A mother was defined as HIV-infected if she had a positive HIV test before/at the birth of the 
child for which immunization was to be assessed for the purposes of this study.  
Vaccination coverage was calculated based on the standard Demographic and health survey 
definition. The numerator was the number of children aged 12-23 months at the time of the 
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survey who had received specified vaccine(s), at any time before the survey, according to 
information from a mother Road-to-Health card or report by respondent. The mothers report 
was used only when no card was shown to the interviewer or there was no record of the 
vaccination. In the absence of both the Road-to-Health card and the mothers report, the child 
was treated as not having been vaccinated for the purposes of this study. 
The denominator was the total number of children aged between 12-23 months at the time of 
the survey.   
 
2.7 Quality control  
A CHF form is only filled in for Children who are between 1 year and 4 years and are resident 
in the households within the DSA. 
When a second visit is being made to the household, two pieces of information exist, on the 
case report forms of that particular household, that help avoid double filling the CHF forms. 
1. Last Visit date to the household 
2. Age of the children in the household.  
The effect of this is that: if the age of the child at the last visit was 12 months and above, then 
a field worker does not bother with a CHF form. However, if the age of a child at the last visit 
was less that 12 months, then the field worker can find out the current age of the child, and if 
the child is 12 months and above, as of the second visit date, then he/she fills in a CHL form.  
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2.8 Data cleaning  
During data cleaning, we used the premise that vaccinations were given in sequence. For 
instance; DTP1 - DTP2 - DTP3. We compared the dates when DTP2 was administered to 
ensure it was after DTP1 was given. Where the dates indicated that DTP1 was given after 
DTP2, we compared the dates of administration of DTP1 with those of OPV1 and HepB1, 
since they are administered at the same time, and made the corrections to DTP1 as 
appropriate. This was done across all the vaccines that are administered at the same time, 
namely; OPV, DTP and HepB. Secondly, we checked for the dates when OPV0 & BCG 
vaccines were given to ensure this was within a few days after birth or at birth.  
 
2.9 Data processing methods and analysis  
Data processing 
The data were captured raw from the household interviews and hand delivered to the Data 
Centre. This was in the form of case report forms. Data in the center is normally captured 
using SQL 2000 and was then transferred to STATA 9.2 for cleaning and analysis. Data 
cleaning was done to check for missing values, incorrect dates, skip patterns as required by the 
questionnaire. This was ensured for accuracy and completeness of the data before analysis. 
Data Analysis  
The primary response variable was vaccination status (1=fully vaccinated; 0=partially 
vaccinated). Differences in proportions were compared using the chi-square or Fisher’s exact 
tests as appropriate. Education level was dichotomized as 1-7 (primary school) years and >7 
years (post primary school), as per the school life in South Africa. Maternal age was 
dichotomized as <25 and >25 years. Wealth index was dichotomized as poorest 40%, the 
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middle 40% or the wealthiest 20% on the assets index scale. These categories of relative 
wealth have been used in other studies in poor provinces in South Africa. 
57,58 
 
The association between Maternal HIV status, distance to health facility, distance to primary 
road, maternal education level, maternal age and socio-economic status with vaccination status 
were examined in the bivariate analysis. For multivariate analysis, we controlled for factors 
that were significant in the univariate analysis in addition to factors that were not significant in 
the univariate but were found significant in other rural areas in the developing countries. 
These included maternal age, maternal education, birth order and sex of the child which 
appeared in all models.  
 
Logistic regression was preferred because the independent variables were continuous and 
categorical in nature. Further, the dependant variable (vaccination status) was dichotomous. 
Sequential logistic regression was used to explore the effect of the independent variables on 
vaccination status. Maternal HIV status was considered to be a more important predictor 
variable, followed by distance to health care facility and to the primary road (model 1). The 
other independent variables were then subsequently adjusted for in model l and a comparison 
of the two models done to find out the best fit.  
 
2.10 Ethics 
The primary project was cleared by an ethics committee in KwaZulu Natal University at 
baseline (2000). Application for recertification is logged annually with the same Ethics 
committee, the last recertification being in November 2006, ethics clearance number E009/00. 
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Approval from the University of Witwatersrand Committee for Research on Human Subjects 
was also obtained; M061028. Permission was obtained from Africa Centre for the use of their 
dataset after filling in a data user agreement formed which was signed by my supervisor and I. 
Study participants were identified using their study IDs instead of their real names during data 
extraction. This was maintained during analysis and reporting.  
 
For the participants in the HIV surveillance, HIV test results were obtained confidentially in a 
number of counselling centres which have been set up for that purpose in the survey area. A 
linked, anonymous voluntary HIV testing system with pre- and post-result counselling that 
used confidential personal pin numbers and handheld computers for result communication had 
been established.
49 
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CHAPTER 3: RESULTS 
3.1 Immunization coverage 
Routine immunization coverage of five vaccinations from 2000 to 2006 is shown in Figure 
3.1.1. BCG vaccine has the highest mean immunization coverage, 92.3% (95% CI 88.4-96.2), 
while measles vaccine is recorded the lowest mean immunization coverage, 79.1% (95% CI 
76.0-82.2). Immunization coverage for the two vaccines is statistically different (P<0.001). 
This can be attributed to the time difference between administrations of the two vaccines. 
BCG is given at birth while measles is given much later – 9 months. Besides, babies who were 
not given BCG vaccine at birth are immunized whenever they are taken to the clinic during the 
first year or for the next immunization visit, at 6 weeks of age. This could account for BCG 
having the highest vaccination coverage.  
 
All vaccinations have the highest coverage in the years 2001-2002, and then have been on the 
decline reaching the lowest levels in 2006. This trend is significant for OPV3 at P=0.03 and 
HepB3 at P=0.04 while BCG and DTP3 were at boarder line significance, at P=0.05 and 
P=0.06 respectively. Similar trends were observed in the national vaccination estimates as 
reported by UNICEF/WHO.
59
   
 
It is noteworthy that 2068 (67.6%) of all the children sampled (n=3058) had been fully 
vaccinated with BCG, OPV3, DTP3, HepB3 and measles, by the end of their first year of age.  
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Routine Immunization coverage by vaccine, children aged 12-23 
months (n=18,171) in Africa Centre
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Figure 2 Percent of immunization coverage by vaccine type among children aged 12-23 
months at the time of interview, Africa Centre DSA South Africa 
A comparison of the mean vaccination coverage between an area served by Africa Centre and 
the mean national vaccination estimates, as reported by UNICEF/WHO
59
, was done (Table 3). 
There were no significant differences observed between vaccination coverage in the Africa 
Centre DSA and the national estimates across all vaccines (P-values>0.05). Except for BCG 
vaccine, whose coverage was 3.9% higher in the Africa Centre DSA compared to the national 
estimates; all the other vaccines had lower coverage in the Africa Centre DSA than nationally 
(Table 3). 
Table 3: Comparing the mean vaccination coverage in Africa Centre DSA and the 
mean national estimates for the period 2000-2006 
Vaccine     DSA (%)    95% CI 
        
National (%)      95% CI P-values 
BCG 92.33 88.44 – 96.22 88.43 80.86 – 95.99 0.254 
OPV3 89.01 85.22 – 92.79 91.29 84.67 – 97.91 0.432 
DTP3 87.13 83.34 – 90.93 91.14 84.40 – 97.89 0.196 
HepB3 83.46 79.70 – 87.22 90.00 83.46 – 96.54 0.051 
Measles 79.07 75.98 – 82.16 82.14 75.44 – 88.84 0.304 
 36 
Timeliness of vaccination 
The results indicate that across all vaccines, 13% to 34% of all children received their vaccines 
according to the immunization schedule, depending on the vaccine, with the majority of them 
receiving their vaccines within 28 days of their due dates. 
Timeliness of all vaccines in Africa Centre DSS
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Figure 3 Distribution of all vaccines, showing a decrease in timeliness of vaccines, Africa 
Centre DSA South Africa 
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3.2 Characteristics of the sample 
The majority of the mothers (64%) had post-primary education (Table 4). The median age of 
the mothers was 24 years (ranging from 13-54). There were an equal number of male and 
female children in the sample. No statistical differences were observed between the total 
number of children vaccinated (3058) and the number of children included in the regression 
analysis (2020) (Table 4). The average distance from a household to a fixed clinic was 3.2 
kms, while the average distance from a household to a mobile vaccination point was 5.7 kms. 
Table 4: Characteristics of the sample population 
Variable 
Total children 
vaccinated, % 
Included in 
regression, %  
 (n=3058) (n=2020) P-value 
Sex of child    
Female 50.1 50.1  
Male 49.9 49.9 0.973 
    
Maternal Education    
Primary Education 35.9 36.2  
Post primary education 64.1 63.8 0.837 
    
Maternal Age (years)    
Under 20 22.9 22.8  
20-29 50.7 49.6  
30+ 26.4 27.6 0.609 
    
Wealth index of household    
Poorest 40.0 39.8  
Middle 40.0 40.2  
Wealthiest 20.0 20.0 0.985 
 Mean, 95% CI Mean, 95% CI P-value 
Distance to fixed clinic (km) 3.13, (3.06-3.21) 3.19, (3.11-3.28) 0.251 
    
Distance to mobile clinic 
point (km) 5.81, (5.69-5.93) 5.74, (5.62-5.88) 0.488 
    
Distance to primary road 
(km) 7.74, (7.48-8.02) 7.76, (7.47-8.05) 0.952 
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3.3. Maternal HIV status  
Of the 3,058 mothers included in the survey, 1217 (40%) knew their HIV status while 1841 
(60%) did not know their HIV status. Among the mothers aged less than 20 years, 33% were 
HIV Positive compared to 13% who were HIV Negative, the rest being of unknown status 
(Table 4). There was no differential effect of wealth index of the households between HIV 
Negative and positive groups.  The HIV Positive women lived closer to a fixed clinic (2.98 
kms vs. 3.31 kms) and a mobile vaccination point (5.75 kms vs. 6.10 kms) compared to those 
who were HIV Negative. 
 
Table 5: Characteristics of the sample by maternal HIV status  
Variable HIV Positive, % HIV Negative, %  
 (n=236) (n=777) P-value 
Sex of child    
Female 48.9 49.9  
Male 51.1 50.1 0.770 
    
Maternal Education    
Primary Education 38.7 37.4  
Post primary education 61.3 62.6 0.709 
    
Maternal Age (years)    
Under 20 32.8 13.2  
20-29 43.8 58.6  
30+ 23.4 28.1 <0.001 
    
Wealth index of household    
Poorest 44.2 40.0  
Middle 40.9 40.4  
Wealthiest 14.9 19.6 0.188 
    
 Mean, 95% CI Mean, 95% CI P-value 
Distance to fixed clinic (km) 2.98, (2.76-3.21) 3.31, (3.18-3.44) <0.001 
    
Distance to mobile clinic 5.75, (5.56-5.95) 6.10, (5.74-6.48) 0.001 
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point (km) 
    
Distance to primary road 
(km) 8.28, (7.83-8.73) 7.37, (6.57-8.17) <0.001 
 
 
3.4 Determinants of vaccination coverage 
 
Tables 6: Adjusted odds for BCG vaccination among children aged 12- 23 months in Africa 
Centre DSA, 2006 (n=2020) 
BCG vaccine Univariate  Multivariate  
Characteristic OR 95% CI P-value aOR 95% CI P-value 
Maternal HIV Status       
Negative 1.00   1.00   
Unknown 0.82 (0.57-1.15) 0.256 0.80 (0.55-1.15) 0.239 
Positive 0.49 (0.31-0.78) 0.003 0.45 (0.28-0.72) 0.001 
Sex       
Females 1.00   1.00   
Males 1.24 (0.90-1.71) 0.194 1.27 (0.92-1.77) 0.139 
Maternal Age (years)       
Linear age 1.01 (0.98-1.03) 0.492 1.02 (0.99-1.05) 0.171 
Maternal Education 
(years)       
Primary education 1.00   1.00   
Post primary education 0.94 (0.36-2.44) 0.894 0.73 (0.51-1.05) 0.089 
Wealth index       
Poorest 1.00   1.00   
Medium 1.28 (0.77-2.10) 0.341 1.37 (0.93-2.01) 0.102 
Wealthiest 1.50 (0.89-2.53) 0.130 1.83 (1.06-3.16) 0.030 
Birth order       
First borne 1.00   1.00   
Second and older borne 1.26 (1.01-1.55) 0.032 0.79 (0.53-1.17) 0.244 
       
Fixed clinic distance 
(kms) 1.02 (0.93-1.11) 0.722 1.01 (0.91-1.12) 0.792 
       
Distance to mobile clinic 
point (km) 0.99 (0.93-1.04) 0.622 0.90 (0.82-0.99) 0.035 
       
Distance from a primary 
road (kms) 0.99 (0.96-1.01) 0.210 0.96 (0.93-0.99) 0.039 
       
OR=odds ratio, aOR=adjusted odds ratio, 95% CI=95% confidence interval 
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In multivariate logistic regression analysis, living further from a primary road and a mobile 
clinic point were associated with being significantly less likely to receive BCG vaccine (Table 
6), adjusted for maternal HIV status, maternal education, maternal age, wealth index, child’s 
sex, birth order, distance to health facility and to a primary road. Children born to mothers 
who are HIV Positive were significantly less likely to be vaccinated with BCG compared to 
those born to HIV Negative mothers. Further, children born to wealthier households were also 
significantly more likely to be vaccinated with BCG compared to those born in the poorest 
households. Being second born or older was also associated with higher likelihood of 
vaccination with BCG vaccine in the univariate but not in the multivariate. 
 
 
Table 7: Adjusted odds for Polio vaccination among children aged 12- 23 months in Africa 
Centre DSA, 2006 (n=2020) 
OPV3 vaccine Univariate Multivariate 
Characteristic OR 95% CI P-value aOR 95% CI P-value 
Maternal HIV Status       
Negative 1.00   1.00   
Unknown 0.79 (0.58-1.09) 0.156 0.81 (0.60-1.09) 0.169 
Positive 0.53 (0.34-0.80) 0.003 0.56 (0.37-0.85) 0.006 
Sex       
Females 1.00   1.00   
Males 1.24 (0.90-1.71) 0.194 1.07 (0.80-1.14) 0.634 
Maternal Age (years)       
Linear age 0.99 (0.98-1.01) 0.913 1.01 (0.99-1.04) 0.228 
Maternal Education 
(years)       
Primary education 1.00   1.00   
Post primary education 0.94 (0.36-2.44) 0.894 0.97 (0.72-1.32) 0.877 
Wealth index       
Poorest 1.00   1.00   
Medium 1.28 (0.77-2.10) 0.341 1.51 (1.08-2.11) 0.014 
Wealthiest 1.50 (0.89-2.53) 0.130 1.72 (1.08-2.75) 0.022 
Birth order       
First borne 1.00   1.00   
Second and older borne 1.12 (0.93-1.36) 0.235 0.76 (0.54-1.08) 0.137 
       
Fixed clinic distance 
(kms) 1.02 (0.93-1.11) 0.722 1.02 (0.93-1.12) 0.624 
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Distance to mobile clinic 
point (km) 0.99 (0.93-1.04) 0.622 0.89 (0.83-0.96) 0.006 
       
Distance from a primary 
road (kms) 0.99 (0.96-1.01) 0.210 0.95 (0.92-0.98) 0.001 
       
OR=odds ratio, aOR=adjusted odds ratio, 95% CI=95% confidence interval 
 
 
In the multivariate logistic regression analysis, living further from a primary road and a mobile 
clinic point were associated with being significantly less likely to be vaccinated with Polio 
vaccine (Table 7), adjusted for maternal HIV status, maternal education, maternal age, wealth 
index, child’s sex, birth order, distance to health facility and to a primary road. Other factors 
associated with polio vaccination included; maternal HIV status and wealth index. Children 
born in wealthier/medium families were more likely to be vaccinated with polio compared to 
those born in poorer families while those born to HIV Positive mothers were less likely to be 
vaccinated compared to those born to HIV Negative mothers. 
 
 
Table 8: Adjusted odds for Diphtheria vaccination among children aged 12- 23 months in 
Africa Centre DSA, 2006 (n=2020) 
DTP3 vaccine Univariate  Multivariate  
Characteristic OR 95% CI P-value aOR 95% CI P-value 
Maternal HIV Status       
Negative 1.00   1.00   
Unknown 0.83 (0.62-1.09) 0.187 0.79 (0.59-1.07) 0.133 
Positive 0.58 (0.39-0.86) 0.007 0.56 (0.37-0.85) 0.006 
Sex       
Females 1.00   1.00   
Males 1.24 (0.90-1.71) 0.194 1.05 (0.81-1.37) 0.695 
Maternal Age (years)       
Linear age 1.00 (0.98-1.02) 0.839 1.00 (0.98-1.02) 0.839 
Maternal Education 
(years)       
Primary education 1.00   1.00   
Post primary education 0.94 (0.36-2.44) 0.894 0.94 (0.71-1.25) 0.688 
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Wealth index       
Poorest 1.00   1.00   
Medium 1.28 (0.77-2.10) 0.341 1.46 (1.07-2.00) 0.016 
Wealthiest 1.50 (0.89-2.53) 0.130 1.68 (1.08-2.59) 0.019 
Birth order       
First borne 1.00   1.00   
Second and older borne 1.11 (0.92-1.32) 0.275 0.83 (0.60-1.14) 0.257 
       
Fixed clinic distance 
(kms) 1.02 (0.93-1.11) 0.722 1.01 (0.92-1.09) 0.805 
       
Distance to mobile clinic 
point (km) 0.99 (0.93-1.04) 0.622 0.88 (0.82-0.95) 0.002 
       
Distance from a primary 
road (kms) 0.99 (0.96-1.01) 0.210 0.95 (0.92-0.97) 0.001 
       
OR=odds ratio, aOR=adjusted odds ratio, 95% CI=95% confidence interval 
 
 
In the multivariate logistic regression analysis, living further from a primary road and a mobile 
clinic point were associated with being significantly less likely to be vaccinated with 
Diphtheria vaccine (Table 8), adjusted for maternal HIV status, maternal education, maternal 
age, wealth index, child’s sex, birth order, distance to health facility and to a primary road. 
Other factors associated with Diphtheria vaccination included; maternal HIV status and wealth 
index. Children born in wealthier/medium families were more likely to be vaccinated with 
Diphtheria compared to those born in poorer families while those born to HIV Positive 
mothers were less likely to be vaccinated with Diphtheria compared to those born to HIV 
Negative mothers. 
 
 
Table 9: Adjusted odds for Hepatitis vaccination among children aged 12- 23 months in 
Africa Centre DSA, 2006 (n=2020) 
HepB3 vaccine Univariate  Multivariate  
Characteristic OR 95% CI P-value aOR 95% CI P-value 
Maternal HIV Status       
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Negative 1.00   1.00   
Unknown 0.78 (0.61-1.01) 0.058 0.75 (0.57-0.98) 0.035 
Positive 0.67 (0.46-0.97) 0.036 0.63 (0.43-0.93) 0.020 
Sex       
Females 1.00   1.00   
Males 1.24 (0.90-1.71) 0.194 1.01 (0.79-1.28) 0.925 
Maternal Age (years)       
Linear age 1.00 (0.98-1.02) 0.640 1.01 (0.99-1.03) 0.204 
Maternal Education 
(years)       
Primary education 1.00   1.00   
Post primary education 0.94 (0.36-2.44) 0.894 0.86 (0.67-1.12) 0.292 
Wealth index       
Poorest 1.00   1.00   
Medium 1.28 (0.77-2.10) 0.341 1.36 (1.02-1.80) 0.033 
Wealthiest 1.50 (0.89-2.53) 0.130 1.70 (1.15-2.52) 0.008 
Birth order       
First borne 1.00   1.00   
Second and older borne 1.13 (0.95-1.34) 0.152 0.85 (0.63-1.14) 0.283 
       
Fixed clinic distance 
(kms) 1.02 (0.93-1.11) 0.722 1.02 (0.95-1.11) 0.530 
       
Distance to mobile clinic 
point (km) 0.99 (0.93-1.04) 0.622 0.88 (0.82-0.94) <0.001 
       
Distance from a primary 
road (kms) 0.99 (0.96-1.01) 0.210 0.95 (0.94-0.98) 0.001 
       
OR=odds ratio, aOR=adjusted odds ratio, 95% CI=95% confidence interval 
 
 
In the multivariate logistic regression analysis, living further from a primary road and a mobile 
clinic point were associated with being significantly less likely to be vaccinated with Hepatitis 
vaccine (Table 9), adjusted for maternal HIV status, maternal education, maternal age, wealth 
index, child’s sex, birth order, distance to health facility and to a primary road. Other factors 
associated with Hepatitis vaccination included; maternal HIV status and wealth index. 
Children born in wealthier/medium families were more likely to be vaccinated with Hepatitis 
compared to those born in poorer families while those born to HIV Positive mothers were less 
likely to be vaccinated with Hepatitis compared to those born to HIV Negative mothers. 
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Table 10: Adjusted odds for Measles vaccination among children aged 12- 23 months in 
Africa Centre DSA, 2006 (n=2020) 
Measles  vaccine Univariate Multivariate  
Characteristic OR 95% CI P-value aOR 95% CI P-value 
Maternal HIV Status       
Negative 1.00   1.00   
Unknown 0.86 (0.68-1.09) 0.215 0.79 (0.62-1.02) 0.071 
Positive 0.73 (0.51-1.02) 0.066 0.69 (0.48-1.00) 0.052 
Sex       
Females 1.00   1.00   
Males 1.24 (0.90-1.71) 0.194 0.91 (0.73-1.14) 0.408 
Maternal Age (years)       
Linear age 1.00 (0.98-1.02) 0.577 1.01 (0.99-1.02) 0.330 
Maternal Education 
(years)       
Primary education 1.00   1.00   
Post primary education 0.94 (0.36-2.44) 0.894 0.93 (0.73-1.19) 0.590 
Wealth index       
Poorest 1.00   1.00   
Medium 1.28 (0.77-2.10) 0.341 1.38 (1.06-1.80) 0.015 
Wealthiest 1.50 (0.89-2.53) 0.130 1.63 (1.13-2.36) 0.008 
Birth order       
First borne 1.00   1.00   
Second and older borne 1.06 (0.91-1.25) 0.418 0.94 (0.72-1.24) 0.699 
       
Fixed clinic distance 
(kms) 1.02 (0.93-1.11) 0.722 1.02 (0.95-1.09) 0.518 
       
Mobile clinic point 
distance (kms) 0.99 (0.93-1.04) 0.622 0.95 (0.89-1.01) 0.112 
       
Distance from a primary 
road (kms) 0.99 (0.96-1.01) 0.210 0.98 (0.96-1.00) 0.081 
       
OR=odds ratio, aOR=adjusted odds ratio, 95% CI=95% confidence interval 
 
In the multivariate logistic regression analysis, children born to mothers who were HIV 
Positive were less likely to be vaccinated with measles vaccine compared to those born to HIV 
Negative mothers, (Table 10), adjusted for maternal HIV status, maternal education, maternal 
age, wealth index, child’s sex, birth order, distance to health facility and to a primary road. 
Children born in wealthier/medium families were also more likely to be vaccinated with 
measles compared to those born in poorer families adjusting for the same factors.
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CHAPTER 4: DISCUSSION 
Vaccination coverage has been used as a proxy measure of health service utilization in 
Africa
10
. We investigated the effect of maternal HIV status on vaccination coverage in 
children aged 12-23 months when controlling for accessibility to the fixed clinic, mobile 
clinic points and primary road and other maternal and child characteristics. We focused 
on this because there is limited research on immunization coverage among children born 
to HIV-positive mothers. 
 
The findings from our analysis can be summarized as follows: children born to HIV-
positive mothers are between 31-55% less likely to be immunized compared to those 
born to HIV-negative mothers. Children living near mobile clinic points are between 10-
12% more likely to be immunized; those living near the primary road are 4-5% more 
likely to be immunized whereas children from wealthier households are between 1.63-
1.83 times more likely to be immunized. 
 
This study confirms the hypothesis that immunization coverage is lower among children 
born to HIV-positive mothers compared to HIV-negative mothers. Also that distance to 
health care facility and to primary road affects the likelihood of vaccination. This is 
especially so in the Africa Centre DSA where people have to walk for 3 to 8 kms to 
access any kind of health care.
48
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4.1 Immunization coverage 
The results indicate that the WHO recommended coverage for routine immunization of 
80% routine coverage
60
 was attained in the Africa Centre DSA across all vaccines except 
for measles. The routine vaccination coverage in the study area also attained at least 80% 
DTP3 coverage, a strategic goal defined in the EPI Regional Strategic Plan, 2001-2005, 
as set by the WHO. Only 22 countries (48%) in Africa attained the WHO recommended 
level by mid-2005.
61
 Measles coverage in the study area would be categorized as high 
routine coverage (>75%) by the standards of the regional EPI. Overall coverage in the 
Africa Centre DSA was not significantly different from South Africa’s national coverage 
as reported by the WHO.
62
 
 
Vaccination coverage differentials among different socio-economic groups, namely the 
poorest, medium and wealthiest, were observed in the multivariate analysis. A study of 
health inequalities in Northern Ghana observed that children in the poorest quintiles were 
less likely to have received measles vaccination.
16
 However the plausible reason for the 
differential effect could be that the wealthiest households appear to be more likely to live 
near the fixed clinics and also close to the primary roads compared to those living in the 
poorest households (appendix 6). The poor thus depend on mobile clinic points, which 
are closer to them, or have to travel to fixed clinics for immunization. Increasing mobile 
vaccination points will thus reduce these indirect costs and hence reduce these 
inequalities of vaccination among the different socio-economic groups. 
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4.2 Maternal HIV status 
Maternal HIV status was found to positively and significantly affect vaccination coverage 
across all the vaccines, in our study area. Children born to HIV-positive mothers were 
less likely to be vaccinated compared to those born to HIV-negative mothers. A previous 
study in Rakai district Uganda showed that children born to HIV-infected mothers had 
lower immunization coverage compared to children born to HIV-negative mothers.
25
 
Further, maternal HIV status has been found to be associated with child survival in South 
west Uganda. Children born to HIV-positive mothers and those born during the period 
when their mothers seroconverted were four times more likely to die compared to those 
born to HIV-negative mothers.
63
  This could be because maternal HIV status is associated 
with higher maternal mortality.  
 
A mother whose health is adversely affected by virtue of her HIV status could find it 
more difficult to walk to a health care facility and have her child vaccinated, compared to 
a more healthy mother. This may cause the child to be deprived of maternal care, which 
involves immunization. The role of the extended family is important in such a case, to 
ensure the continued support of the child, though the child support which is given in this 
case might not be as adequate as the mother would give. This is especially common in 
settings with high HIV prevalence which may cause increased burden of childcare among 
relatives living in already resource constrained settings.
64
 
 
In this study, we cannot comment on the effect of the child’s HIV status on their 
likelihood of vaccination. However, previous studies have shown that irrespective of their 
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own infection status, all children born to mothers who were at an advanced level of HIV 
or who died during follow-up were at considerably increased risk of death compared to 
those whose mothers survived or were at a less advanced stage of the disease. This 
association was especially strong for uninfected children.
65
 
 
Another plausible explanation could be that mothers who are HIV-positive have lower 
scores of perception to general health, physical functioning and overall quality of life.
66
 
This may have a negative effect on the health seeking behaviour of the mother where she 
may prefer to use her resources for other household purposes other than improving her 
health and that of her child. 
 
Further, mothers who are HIV-positive are faced with a challenge of distribution of 
scarce economic resources. They either use the scarce resources to seek health care for 
themselves or for their children or to feed their households. This burden is further 
increased if their children are HIV-positive and in need of extra care, as well as the fear 
of leaving orphaned children. HIV-positive women are also more vulnerable than others 
because they will have diminishing strength with which to continue functioning in their 
roles as mothers and caretakers of the family. 
64
 
 
4.3 Distance to health care facility 
The results shown here are based on the actual distance from the household to a fixed 
clinic or a mobile clinic point or a primary road. Distance to fixed clinic was not found to 
be significant. However, distance to primary road was positively associated with 
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vaccination coverage except for measles vaccine. Children living further from a primary 
road were less likely to be vaccinated. A probable explanation would be that a 
mother/caregiver who is taking a child for vaccination would have to overcome the 
distance to primary road. From there public transport can be used to get the clinic. The 
time spent while using public transport is of no consequence, so long as a 
mother/caregiver gets to the primary road and hence is able to access the transport. One 
study done at the Africa Centre DSA found that though the majority of the people walk to 
their nearest facility, one-third of the population use public transport.
67
 
 
We found that distance to the primary road was significant for BCG, DTP3, HepB3 and 
OPV3 vaccines, but it was not significant for measles vaccine. This could possibly be due 
to the fact that BCG, DTP3, HepB3 and OPV3 are administered much closer to birth 
(within the first four months after birth) while measles is administered much later than 9 
months. More attention is given to a child at this early age compared to when a child is 
older. This is evident from the fact that the mean immunization coverage for these 
vaccines is higher compared to that of measles vaccine. The mother/caregiver would 
therefore make every effort to overcome the distance to the primary road for the sake of 
her child’s’ health at this tender age.  
 
Distance to the mobile clinic point is positively associated with vaccination coverage. 
BCG is administered only once whereas OPV3, DTP3 and HepB3 are administered three 
times at specified intervals. These subsequent visits to the clinic need advance planning 
and an appreciation of the importance of receiving vaccines at the right intervals. BCG is 
 49 
given at birth or at any subsequent visit to the clinic before the child is 12 months and 
hence the diminishing effect of distance to mobile clinic points.  
 
Mobile clinic points are located near poor people who live further from the fixed clinics 
(appendix 6). Thus mobile clinic points could be bridging the gap of mothers living in 
poor households walking for very long distances to get to fixed clinics. Such a mother 
would have to weigh the opportunity cost of waiting for the scheduled time(s) of a mobile 
clinic versus travelling a long distance to attend a fixed clinic. This however assumes that 
mobile clinics in the study area have consistent planning and there are no disparities in 
the quality of service between the fixed and the mobile clinic. Such disparities can occur 
when health workers in the mobile clinics have long days when they have to deal with the 
numerous clients. This may cause them to rush their services or lose their patience when 
handling the clients. Quality of the health care services has been found to affect their 
utilization.
68
 
 
It is noteworthy that mothers’ education was not significantly associated with 
immunization coverage across all the vaccines. This has been found in other studies.
36
 In 
our study area, 64% of the mothers had post-primary education, while the rest had 
primary education and below. This indicates that the literacy level in our study area is 
higher than most rural areas in developing countries.  
 
In the Africa Centre DSA, there were no gender differences in immunization coverage, as 
found in other studies.
36
 This is a representation of actual practice where there is no 
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gender discrimination in relation to child immunization. The gender ratio in our study 
was 1: 0.99 which is equal to the average gender ratio in South Africa
69
, an expression of 
equal preference of children.  
 
4.4 Limitations  
In the light of the above findings, the methodology has some limitations. All vaccinations 
are recorded on an individual’s vaccination card (Road-to-Health card) kept by the 
mother. In the absence of a Road-to-Health card, maternal spontaneous vaccination recall 
was used. This may cause recall bias since the mother may not adequately recall the 
precise vaccines and the vaccination dates. However, this has been used in other studies 
estimating immunization coverage in other settings.
25,70
 Moreover; a study in Egypt 
showed that using ‘card plus history’ is a commonly used source of vaccination 
information because mother’s reports of their children’s vaccination status are of 
remarkable quality - even among uneducated mothers.
 70 
 
In our study, only 42.5% of the respondents had vaccination cards. This is much lower 
compared to the SADHS which shows that 75% of children aged 12-23 months had road-
to-health cards.
69
 Had our survey relied on immunization cards only, we were unlikely to 
cover a large population of children in our study area. HIV status of the mother was 
available for only 1217 out of 3058 (40%) of the sample. To solve this problem of a small 
sample size, we also included respondents whose HIV status was unknown.  
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Data is collected once every six months from a key informant in the household. This may 
introduce recall bias since the informant may not recall accurately the information 
concerning all the members of the household over a period of the last six months. 
 
HIV surveillance is not conducted on all the resident members within the demographic 
surveillance area. It is collected voluntarily on members of the household who consent to 
be included in the survey. This reduced the sample size of the mothers who knew their 
HIV status. HIV status of the mother was available for only 1217 out of 3058 (40%) of 
the sample. For purposes of our analysis, we included both groups of mothers who had 
known and unknown HIV status. Therefore the strength of the association for unknown 
group is an estimate between the range for HIV Negative and Positive status and could 
not be quantified to reflect the true picture. 
 
Further, our study defined maternal HIV Positive status as having had a positive HIV test 
before/at the birth of the child for which immunization was to be assessed. However, a 
mother might have become infected after birth, with consequent negative effects on 
child’s health and immunization status, but was considered HIV Negative for the 
purposes of this study. This may underestimate the real numbers of HIV positive mothers 
compared with HIV negative mothers. 
 
The sampling strategy used in this study could have introduced selection bias. Out of 18, 
171 children whose vaccination information was available, only 2,020 were analysed 
because they had complete information on the independent variables.  
 52 
 
Vaccination data did not include Haemophilus influenzae type B (Hib) vaccine which 
was routine in EPI since 1999. This is because data on Hib vaccine was only collected in 
the ACDIS as from January 2008. 
 
CHAPTER 5: CONCLUSION  
This study leads to the conclusion that children living near a mobile clinic point and near 
a primary road network were more likely to be vaccinated compared to those whose 
households were located further. Children born to HIV-positive mothers were less likely 
to be vaccinated compared to those born to HIV-negative mothers. Immunization 
coverage improves with wealth: children from the less poor households being more likely 
to be vaccinated compared to those in the poorest households. There is no gender 
difference among children in the society in terms of vaccination status. 
 
Immunization has without doubt been shown to improve child survival, and given the fact 
that vaccines are given free of charge in sub-Saharan Africa, it is imperative to address 
the determinants that are barriers to vaccination coverage. Vaccination coverage 
especially in developing countries is further hampered by the HIV/AIDS epidemic. This 
is not only because the children born to HIV-positive mothers are less likely to be 
immunized, but also because their survival rate is reduced by virtue of their mothers’ 
increased risk of death as a result of their HIV Status. Further, these children are at high 
risk of mother-to-child transmission of HIV infection during birth.   
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CHAPTER 6: RECOMMENDATIONS 
Interventions aimed at HIV-positive mothers are well needed especially in the rural areas. 
ARV rollouts need to be intensified especially in these areas where there are scarce 
resources and hence the burden of HIV is higher. Alongside the ARV rollouts, socio 
mobilisation aimed at increasing the demand for immunization could be done to reduce 
the differentials in immunization of children due to maternal HIV status. These include 
conducting trainings to health educators, such as VCT workers, on vaccination schedules 
and on vaccine policies. These VCT workers would then encourage HIV-infected 
mothers to complete childhood immunisation.  
 
Given the primacy of distance to the health care facility in vaccination coverage coupled 
with coverage differentials by socio-economic status, steps to improve access especially 
to the poor need to be taken. Mobile clinics are one of the interventions that have without 
doubt helped reduce health utilization differentials among the different socio economic 
groups. It has targeted the poor who have limited access to fixed clinics. There is need 
however to increase the number of vaccination points in the study area to cater for the 
differentials in vaccination across the social economic groups. These mobile vaccination 
points should be located further from the cities and should target the poorest areas within 
the study site. Further, intensive outreach services including placement of community 
health workers within communities with limited access to heath care facilities can be 
adopted to reduce prevailing socio economic differentials in vaccination. 
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There is also need for continued community awareness on immunization. The health 
workers should continue disseminating information to the members for instance on the 
importance of the timely completion of immunizations. Heath workers can target mothers 
coming for ante-natal clinic and educate them on the benefits of vaccination of their 
unborn children. 
 
There should be periodic limited and targeted mass campaigns (mop ups) in the high-risk 
populations. This includes areas within the sub-district that have the poorest EPI 
vaccination coverage, poor surveillance information, densely populated areas and people 
living in areas with heavy migration.  
 
To improve the quality of immunization services, the local authorities should establish a 
mechanism of tracking children who have defaulted their vaccinations.  
 
Further research into this subject is needed. For instance qualitative research exploring 
reasons why mothers do not take their children to be vaccinated. Drop out rates were 
observed, in this study, to be between (OPV3, DTP3, HepB3) and measles ranging 
between 9% and 15%. A further investigation of factors associated with these drop-out 
rates is necessary. This is because drop-out rates are used as a measure of the quality of 
vaccination services. 
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APPENDIX 6 
Relationship between wealth index categories and distance (to fixed clinic, mobile 
clinic and primary road) 
 
Comparing distance to the fixed clinic by wealth index of the household 
 
 
Wealth index 
of household 
Mean 95% CI Wealth index 
of household 
Mean 95% CI P-value 
Poorest 4.09 (3.95-4.21) Medium 2.95 (2.83-3.06) <0.001 
Poorest 4.09 (3.95-4.21) Wealthiest 1.94 (1.80-2.07) <0.001 
 
Comparing distance to mobile clinic by wealth index 
 
Wealth index 
of household 
Mean 95% CI Wealth index 
of household 
Mean 95% CI P-value 
Poorest 4.37 (4.21-4.54) Medium 5.99 (5.79-6.18) <0.001 
Poorest 4.37 (4.21-4.54) Wealthiest 7.98 (7.76-8.22) <0.001 
 
 
Comparing distance to primary road by wealth index 
 
Wealth index 
of household 
Mean 95% CI Wealth index 
of household 
Mean 95% CI P-value 
Poorest 10.35 (9.92-10.78) Medium 7.23 (6.77-7.69) <0.001 
Poorest 10.35 (9.92-10.78) Wealthiest 3.69 (3.22-4.17) <0.001 
 
 
 
 
